(Reuters) – The U.S. Food and Drug Administration (FDA) on Monday published the final rule to ensure safety and effectiveness of laboratory developed tests (LDTs), which are designed, manufactured and used within a clinical laboratory.
(Reporting by Mariam Sunny in Bengaluru; Editing by Shinjini Ganguli)
Comments